Together with PTPs that impinge upon cellular contacts (DUSP26, PTPRZ1) and phospholipid signaling (MTMR4, PTEN and PTPRN2) they provide novel cues to explore and design glioma treatment options. This evidence concerns the gene MTMR4 and glioma.